2021. Comparison of the Efficacy of Generation 1 and 2 Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Patients with EGFR Positive Mutations. Indian Journal of Forensic Medicine & Toxicology. 15, 3 (May 2021), 4316–4324. DOI:https://doi.org/10.37506/ijfmt.v15i3.15970.